'25 mg' diaporamas de présentation

Lecture 11 Neutrino Losses and Advanced Stages of Stellar Evolution - I

Lecture 11 Neutrino Losses and Advanced Stages of Stellar Evolution - I. The late stages (> helium burning) of evolution in massive stars are characterized by huge luminosities, carried away predominantly by neutrinos, and consequently by short time scales.

837 views • 69 slides

????? ????? ?????? ?????? ?????? ?????? ????? ?????? ??????????-

979 views • 60 slides

Hypertension: Evidence-based Strategies

Hypertension: Evidence-based Strategies. Vijay Bhandari , MD CCRMC Noon Conference July 31, 2009. Disclaimers. This talk is only about medications There are few wrong ways to treat HTN. Epidemiology. Affects > 25% of adults in the developed world Why treat?

695 views • 49 slides

Phase 2 Evaluation of Intravitreal Bevacizumab for DME

Phase 2 Evaluation of Intravitreal Bevacizumab for DME. Sponsored by the National Eye Institute, National Institutes of Health, U.S. Department of Health and Human Services. Study Objectives.

586 views • 44 slides

D- GONADAL HORMONES: ESTROGENS AND ANDROGENS

731 views • 40 slides

Math for Medications

620 views • 37 slides

Previous Clinical Experience

Previous Clinical Experience. Victor Sandor, MD VP Global Oncology Drug Development Incyte Corporation. The RESPONSE Trial CINC424B2301. Outline. INC424 clinical experience in healthy volunteers Key findings from: Single and multiple ascending dose studies Drug interaction studies

504 views • 33 slides

579 views • 31 slides

TEMSIROLIMUS

366 views • 27 slides

Rilpivirine ( Edurant ): A New NNRTI

Rilpivirine ( Edurant ): A New NNRTI. David Spach, MD Clinical Director, Northwest AETC Professor of Medicine, University of Washington. Presentation Prepared by: David Spach, MD Last Updated: July 8, 2011. Antiretroviral Therapy. Rilpivirine ( Edurant ). ANTIRETROVIRAL THERAPY.

424 views • 22 slides

E. Gronda, MD, FESC Cardiology Division Cardiovascular Department

357 views • 21 slides

Clinical Case Heart Failure

Clinical Case Heart Failure. ISL , 63 y. Marzo 2003. Marzo 2017. C iclofosfamida H Doxurrubicina O Vincristina P rednisona. ISL , 63 y. Ambulatory. Octuber 2017. October 2017. Furosemida 40 mg Bisoprolol 1,25 mg Espinolactona 12,5 mg Captopril 6.25 mg. Transesophageal Echo.

850 views • 19 slides

???????????? ?? ?????? ???? ????? ???????? ?????????? ???????

???????????? ?? ?????? ???? ????? ???????? ?????????? ???????. ??????? ???? (??? ????): ????? ?? Neurotransmission ???. Neurotransmission : ???? ???? ?? ????? ?????(????????????) ? ????? ?? ?? ???? ?????? ?? ???? ???? ? ????? ??????? ?? ??. ???? ???????? ?? ??? ???? ?? ????? ???? ??????? ???.

341 views • 19 slides

Introductory Pharmacology Decimals

Introductory Pharmacology Decimals. Ann MacLeod, RN, BScN, MPH. Objectives. Read and write decimals Compare size of decimals Convert Decimals to Fractions and back Add, subtract and multiply decimals Round decimals to the nearest 10th. Writing Decimals.

465 views • 17 slides

MGH Research in IPF: Identifying New Targets for Effective Drug Therapies

MGH Research in IPF: Identifying New Targets for Effective Drug Therapies. Andrew M. Tager, M.D. Interstitial Lung Disease Program Pulmonary and Critical Care Unit Massachusetts General Hospital Harvard Medical School. Unmet Need for Effective IPF Therapy.

272 views • 15 slides

Risperdal Online

Risperdal Online.

233 views • 13 slides

Buy Premarin Cream Uk

Buy Premarin Cream Uk.

403 views • 12 slides

Ostarine

Osta MAX sarm by Gun Show Supplements. Lets take a minute to review this amazing supplement. Osta MAX contains Ostarine (a.k.a Enobosarm, MK-2866, GTx-024) (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)

192 views • 6 slides

22 Ne( ? , ? /n)

22 Ne( ? , ? /n). 22 Ne( ? , n) 25 Mg reaction is the main source of neutrons for s-process - there is competition from the 22 Ne( ? , ? ) 26 Mg reaction - s-process is the origin of nuclides heavier than iron.

140 views • 2 slides

Place title here, using this font

Place title here, using this font. Place authorship here, using this font and using superscript for institutional affiliation 1 , etc. Place institutional affiliation here, using this font. METHODS. BACKGROUND. RESULTS. Response

82 views • 1 slides